Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Hu, Lijuan ^a   Lind, Thomas ^a   Sundqvist, Anders ^a,b   Jacobson, Annica ^a   Melhus, Håkan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CD14 ANTIGEN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RETINOIC ACID; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NUCLEAR FACTOR OF ACTIVATED T CELL CYTOPLASMIC 1; UNCLASSIFIED DRUG; TNFRSF11A PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; NORMAL HUMAN; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; SUPERNATANT; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; MOUSE; OSTEOCLAST; PHYSIOLOGY; STEM CELL;

ANIMALIA; MURINAE; MUS;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; HUMANS; MICE; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RNA, MESSENGER; STEM CELLS; TRETINOIN;

EID: 78149418191     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013305     Document Type: Article

References (50)

1. Melhus H (2003) Vitamin A and fracture risk. In: New SA, Bonjour J-P, eds. Nutritional Aspects of Bone Health. Cambridge, UK: The Royal Society of Chemistry. pp 369-402.
2. Barnicot N, Datta S (1956) Vitamin A and bone. In: Bourne G, ed. The biochemistry and physiology of bone. New York: Academic Press Inc. pp 507-537.
3. Feskanich D, Singh V, Willett WC, Colditz GA (2002) Vitamin A intake and hip fractures among postmenopausal women. JAMA 287: 47-54.
4. Michaelsson K, Lithell H, Vessby B, Melhus H (2003) Serum retinol levels and the risk of fracture. N Engl J Med 348: 287-294.
5. Melhus H, Michaelsson K, Kindmark A, Bergstrom R, Holmberg L, et al. (1998) Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med 129: 770-778.
6. Promislow JH, Goodman-Gruen D, Slymen DJ, Barrett-Connor E (2002) Retinol intake and bone mineral density in the elderly: the Rancho Bernardo Study. J Bone Miner Res 17: 1349-1358.
7. Mic FA, Molotkov A, Benbrook DM, Duester G (2003) Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis. Proc Natl Acad Sci U S A 100: 7135-7140.
8. Bastien J, Rochette-Egly C (2004) Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328: 1-16.
9. Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4: 638-649.
10. Lerner UH (2004) New Molecules in the Tumor Necrosis Factor Ligand and Receptor Superfamilies with Importance for Physiological and Pathological Bone Resorption. Crit Rev Oral Biol Med 15: 64-81.
11. Kearns AE, Khosla S, Kostenuik PJ (2008) Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 29: 155-192.
12. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, et al. (1999) Commitment and differentiation of osteoclast precursor cells by the sequential expression of c- Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 190: 1741-1754.
13. Ross FP, Teitelbaum SL (2005) alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol Rev 208: 88-105.
14. Dai XM, Ryan GR, Hapel AJ, Dominguez MG, Russell RG, et al. (2002) Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99: 111-120.
15. Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, et al. (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A 97: 1566-1571.
16. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, et al. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323.
17. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, et al. (1999) RANK is essential for osteoclast and lymph node development. Genes Dev 13: 2412-2424.
18. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, et al. (1998) osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12: 1260-1268.
19. Kim K, Kim JH, Lee J, Jin HM, Kook H, et al. (2007) MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109: 3253-3259.
20. Zhao B, Takami M, Yamada A, Wang X, Koga T, et al. (2009) Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med 15: 1066-1071.
21. Saneshige S, Mano H, Tezuka K, Kakudo S, Mori Y, et al. (1995) Retinoic acid directly stimulates osteoclastic bone-resorption and gene-expression of cathepsin K/OC-2. Biochemical J 309: 721-724.
22. Oreffo RO, Teti A, Triffitt JT, Francis MJ, Carano A, et al. (1988) Effect of vitamin A on bone resorption: evidence for direct stimulation of isolated chicken osteoclasts by retinol and retinoic acid. J Bone Miner Res 3: 203-210.
23. Conaway HH, Grigorie D, Lerner UH (1997) Differential effects of glucocorticoids on bone resorption in neonatal mouse calvariae stimulated by peptide and steroid-like hormones. J Endocrinol 155: 513-521.
24. Scheven BA, Hamilton NJ (1990) Retinoic acid and 1,25-dihydroxyvitamin D3 stimulate osteoclast formation by different mechanisms. Bone 11: 53-59.
25. Kneissel M, Studer A, Cortesi R, Susa M (2005) Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodents. Bone 36: 202-214.
26. Walsh CA, Beresford JN, Birch MA, Boothroyd B, Gallagher JA (1991) Application of reflected light microscopy to identify and quantitate resorption by isolated osteoclasts. J Bone Miner Res 6: 661-671.
27. Jacobson A, Johansson S, Branting M, Melhus H (2004) Vitamin A differentially regulates RANKL and OPG expression in human osteoblasts. Biochem Biophys Res Commun 322: 162-167.
28. Nakajima H, Kizaki M, Sonoda A, Mori S, Harigaya K, et al. (1994) Retinoids (all-trans and 9-cis retinoic acid) stimulate production of macrophage colonystimulating factor and granulocyte-macrophage colony-stimulating factor by human bone marrow stromal cells. Blood 84: 4107-4115.
29. Colucci S, Grano M, Mori G, Scotlandi K, Mastrogiacomo M, et al. (1996) Retinoic acid induces cell proliferation and modulates gelatinases activity in human osteoclast-like cell lines. Biochem Biophys Res Commun 227: 47-52.
30. Kaji H, Sugimoto T, Kanatani M, Fukase M, Kumegawa M, et al. (1995) Retinoic acid induces osteoclast-like cell formation by directly acting on hemopoietic blast cells and stimulates osteopontin mRNA expression in isolated osteoclasts. Life Sci 56: 1903-1913.
31. O'Neill RP, Jones SJ, Boyde A, Taylor ML, Arnett TR (1992) Effect of retinoic acid on the resorptive activity of chick osteoclasts in vitro. Bone 13: 23-27.
32. Conaway HH, Persson E, Halen M, Granholm S, Svensson O, et al. (2009) Retinoids inhibit differentiation of hematopoetic osteoclast progenitors. FASEB J 23: 3526-38.
33. Ishimi Y, Ohmura M, Wand X, Yamagchi M, Ikegami S (1999) Inhibition by carotenoids and retinoic acid of osteoclast-like cell formation induced by boneresorbing agents in vitro. J Clin Biochem Nutr 27: 113-122.
34. Xu J, Tan JW, Huang L, Gao XH, Laird R, et al. (2000) Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand. J Bone Miner Res 15: 2178-2186.
35. Sorensen MG, Henriksen K, Schaller S, Henriksen DB, Nielsen FC, et al. (2007) Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. J Bone Miner Metab 25: 36-45.
36. Fuller K, Kirstein B, Chambers TJ (2006) Murine osteoclast formation and function: differential regulation by humoral agents. Endocrinology 147: 1979-1985.
37. Kirstein B, Chambers TJ, Fuller K (2006) Secretion of tartrate-resistant acid phosphatase by osteoclasts correlates with resorptive behavior. J Cell Biochem 98: 1085-1094.
38. Delva L, Cornic M, Balitrand N, Guidez F, Miclea JM, et al. (1993) Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 82: 2175-2181.
39. Zhou DC, Kim SH, Ding W, Schultz C, Warrell RP, Jr., et al. (2002) Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo. Blood 99: 1356-1363.
40. Muindi J, Frankel SR, Miller WH, Jr., Jakubowski A, Scheinberg DA, et al. (1992) Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood 79: 299-303.
41. Wang X, Wu J, Shidoji Y, Muto Y, Ohishi N, et al. (2002) Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation. J Bone Miner Res 17: 91-100.
42. Yonezawa T, Hasegawa S, Ahn JY, Cha BY, Teruya T, et al. (2007) Tributyltin and triphenyltin inhibit osteoclast differentiation through a retinoic acid receptor-dependent signaling pathway. Biochem Biophys Res Commun 355: 10-15.
43. Woods C, Domenget C, Solari F, Gandrillon O, Lazarides E, et al. (1995) Antagonistic role of vitamin D3 and retinoic acid on the differentiation of chicken hematopoietic macrophages into osteoclast precursor cells. Endocrinology 136: 85-95.
44. Sporn MB, Clamon GH, Dunlop NM, Newton DL, Smith JM, et al. (1975) Activity of vitamin A analogues in cell cultures of mouse epidermis and organ cultures of hamster trachea. Nature 253: 47-50.
45. Kindmark A, Melhus H, Ljunghall S, Ljunggren O (1995) Inhibitory effects of 9- cis and all-trans retinoic acid on 1,25(OH)2 vitamin D3-induced bone resorption. Calcif Tissue Int 57: 242-244.
46. Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7: 292-304.
47. Nakashima T, Takayanagi H (2008) The dynamic interplay between osteoclasts and the immune system. Arch Biochem Biophys 473: 166-171.
48. Day CJ, Kim MS, Stephens SR, Simcock WE, Aitken CJ, et al. (2004) Gene array identification of osteoclast genes: differential inhibition of osteoclastogenesis by cyclosporin A and granulocyte macrophage colony stimulating factor. J Cell Biochem 91: 303-315.
49. Karsdal MA, Hjorth P, Henriksen K, Kirkegaard T, Nielsen KL, et al. (2003) Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J Biol Chem 278: 44975-44987.
50. Ji JD, Park-Min KH, Shen Z, Fajardo RJ, Goldring SR, et al. (2009) Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. J Immunol 183: 7223-7233.